New vitamin B12 therapy shows promise against deadly brain cancer

Researchers have developed a new vitamin B12-based compound that can penetrate the blood-brain barrier and target glioblastoma, one of the deadliest brain cancers. In animal studies, the compound accumulated in tumor tissue and released nitric oxide directly to cancer cells. When combined with existing treatments, it significantly enhanced their tumor-fighting power. According to ScienceDaily, the findings offer a promising new approach to treating a cancer that currently has few effective options.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton